Craneware (LON:CRW) Given “Buy” Rating at Berenberg Bank

Craneware (LON:CRW)‘s stock had its “buy” rating restated by analysts at Berenberg Bank in a report released on Tuesday, Digital Look reports. They currently have a GBX 2,600 ($32.89) price target on the stock. Berenberg Bank’s price target indicates a potential upside of 10.26% from the company’s current price.

Craneware Trading Up 2.1 %

Craneware stock opened at GBX 2,358 ($29.83) on Tuesday. Craneware has a one year low of GBX 1,290 ($16.32) and a one year high of GBX 2,509.20 ($31.74). The company’s fifty day moving average price is GBX 2,290.41 and its two-hundred day moving average price is GBX 2,135.65. The company has a debt-to-equity ratio of 19.15, a current ratio of 0.78 and a quick ratio of 1.00. The company has a market capitalization of £832.85 million, a price-to-earnings ratio of 11,285.24 and a beta of 0.14.

Craneware Company Profile

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.